Skip to content

Branched-chain amino acids during acute phase for patients with hepatic encephalopathy: A systematic review and meta-analysis

Branched-chain amino acids during acute phase for patients with hepatic encephalopathy: A systematic review and meta-analysis - Branched-chain amino acids during acute phase for patients with hepatic encephalopathy: A systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054559
Enrollment
Unknown
Registered
2024-06-04
Start date
2024-06-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic encephalopathy

Interventions

None listed

Sponsors

Guideline committee of Japan Resuscitation Council (Neuroresuscitation)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Randomized controlled trials. 2) Adult patients with hepatic encephalopathy. 3) Comparison BCAA administration in emergency room and/or intensive care unit with placebo. 4) Japanese or English

Exclusion criteria

Exclusion criteria: Conference abstract

Design outcomes

Primary

MeasureTime frame
Mortality

Secondary

MeasureTime frame
Improvement of disorientation, serious adverse events, nausea and diarrhea, and increased albumin

Countries

Japan

Contacts

Public ContactTomoaki Yatabe

Nishichita General Hospital Emergency department

yatabe.tomoaki@katch.ne.jp0562335500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026